XGen Pharmaceuticals DJB
Alison Bridenbaugh has extensive work experience, starting in 2008 as a Laboratory Technician at Johnson & Johnson. Alison then worked at Bausch + Lomb from 2009 to 2014 as a Technician IV in Chemistry. Following this, they joined KJT Group as a Project Coordinator/Project Manager from 2014 to 2016. Alison then worked at M3 Global Research as a Project Manager from 2016 to 2017. After that, they joined BioTel Research (Cardiocore & VirtualScopics) as a Project Manager from 2017 to 2018. Currently, Alison is working at XGen Pharmaceuticals DJB. Alison started as a Project Manager of New Drug Development from 2018 to 2021, then became a Manager of Project Management from 2021 to 2022, and is currently serving as an Associate Director of Project Management.
Alison Bridenbaugh has a Bachelor of Science degree in Biochemistry from Keuka College. Prior to attending college, they completed their high school education at Webster Thomas High School. There is no specific information available regarding the start and end years of their education at either institution.
This person is not in any offices
XGen Pharmaceuticals DJB
Approaching the end of a 20 year career at a major pharmaceutical company, Dan Badia made a discovery. Where larger companies found obsolescence in small markets or low-profit yielding drugs, Dan saw reliable solutions proven to be effective and affordable alternatives for healthcare. With his wife, Shirley Harmening, Dan founded a company in 1973 on a bridge table in his bedroom. In just 14 years, this company would outgrow its birthplace and find a home in lower upstate New York. That growth would be sustained by introducing injectables into an established product line, mainly consisting of anti-infective, compounding powders. In 2003, that company would become X-GEN Pharmaceuticals, Inc. Affirming Dan’s original vision while embracing a dynamic industry, family-owned X-GEN Pharmaceuticals, Inc. remained a leader in generic, anti-infective pharmaceuticals. In this our 50th year in affiliation, we honor this heritage by carrying our founder’s initials in our new name, XGen Pharmaceuticals DJB. With reverence for the past and a passion for the future, we expect big results, driven by bold solutions and delivered by real people.